TRT on TikTok: separating testosterone facts from gym-bro mythology

What did @wyldstylefit actually say?

The creator described a weekly protocol combining 140mg of testosterone with 60mg of nandrolone in a single blend, split into two injections. On top of that, they're taking three IUs of growth hormone five days a week. They also mentioned something called "Reda True-Tied," which they described as a "GOP3" and an appetite suppressant. This video is framed as a personal disclosure, not medical advice, but with 5.8K views, a lot of people are going to treat it as a template.

Let me be direct: this is not a standard TRT protocol. Therapeutic testosterone replacement for hypogonadism typically ranges from 75 to 100mg per week in clinical settings. Adding nandrolone and pharmaceutical-grade HGH puts this squarely in performance-enhancement territory, not hormone optimization for a medical condition. That distinction matters, legally and physiologically.

Does the science back this up?

Some of it, partially. Nandrolone decanoate has legitimate clinical research behind it, and HGH is FDA-approved for specific diagnoses. But the way these compounds are being used here doesn't map cleanly onto that evidence base.

Nandrolone has been studied for muscle wasting in HIV patients and for anemia associated with renal failure (Sarwar et al., 2010, Journal of Cachexia, Sarcopenia and Muscle). At therapeutic doses, it has a documented effect on lean mass. But stacking it with testosterone introduces compounding suppression of the hypothalamic-pituitary-gonadal axis. A 2020 review in Endocrine Reviews by Bhasin et al. confirmed that anabolic-androgenic steroid combinations suppress endogenous testosterone production more aggressively than single-agent use.

Three IUs of HGH five days per week is above what most anti-aging or wellness clinics prescribe for adults, where 1 to 2 IUs daily is more typical. The GH Research Society's 2019 consensus guidelines recommend starting adult GH replacement at 0.1 to 0.3mg per day, scaling based on IGF-1 response. Three IUs daily would be toward the higher end even for GH-deficient patients.

What did they get wrong (or right)?

They got the splitting of injections right. Dividing a weekly dose into two injections, a common practice called twice-weekly dosing, does produce more stable serum levels and reduces peak-to-trough fluctuations. That part is consistent with how endocrinologists approach TRT pharmacokinetics (Rastrelli et al., 2018, Sexual Medicine Reviews).

What they got wrong, or at least left dangerously incomplete: no mention of monitoring. Running testosterone plus nandrolone without tracking hematocrit, lipid panels, or estradiol is how people end up with polycythemia or suppressed HDL. Nandrolone in particular has a notable effect on HDL cholesterol, with some studies showing reductions of 20 to 30 percent (Hartgens and Kuipers, 2004, Sports Medicine).

The "Reda True-Tied" reference is garbled, and I'll address that below, but describing any compound as simply working as "an appetite suppressant" without context on mechanism or risk is a pattern that should concern anyone watching this for guidance.

What should you actually know?

The compound the creator likely means is Retatrutide, a triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. Calling it a "GOP3" is an approximation of that triple-receptor mechanism. Retatrutide is still in clinical trials as of this writing. It is not FDA-approved. Phase 2 data published in 2023 in the New England Journal of Medicine (Jastreboff et al.) showed meaningful weight loss results, but that research was in a controlled trial population, not people stacking it with anabolic hormones.

There is no safety data on combining Retatrutide with supraphysiologic testosterone, nandrolone, and HGH. None. Anyone telling you that combination is fine is working from zero evidence. The appetite suppression angle sounds benign, but in a stack that already includes HGH, which affects glucose metabolism, adding a glucagon receptor agonist introduces real complexity around blood sugar regulation.

If you're considering any part of this protocol, you need baseline bloodwork, a prescribing physician who will monitor you, and an honest conversation about what you're actually trying to treat versus optimize.

The bottom line

This video is someone describing their personal stack, not giving medical advice. Give them credit for that transparency. But the protocol itself combines compounds at doses above standard therapeutic ranges, includes an unapproved investigational drug, and mentions zero monitoring or safety context. The individual pieces have research behind them in specific clinical populations. The combination, at these doses, does not.